Philippe Sarret's laboratory recently obtained important grants that will be used to support his research projects which aim to identify and develop new drugs to treat chronic pain. It is estimated that 70% of patients taking prescription analgesics for chronic pain are not relieved, in addition to living with side effects that can have a considerable impact on their quality of life, such as constipation, respiratory problems, tolerance, dependance and anxiety.
Research and experts are suggesting medical cannabis could help reduce opioid consumption, as a less dangerous alternative to treat chronic pain. Scientific American published an article summarizing recent research about the subject, and includes a discussion of research on the safety of cannabis used to treat chronic pain published by Mark Ware and colleagues in the Journal of Pain.
"Experimental clinical trials would provide the most definitive proof on any cause-and-effect relation between medical cannabis and reduced opioid use" says Mark Ware.